Scales Corporation stock weighs H1 growth against Esro risk

Published on 10/07/2026 at 05:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Scales Corporation stock was last at NZD 6.45 on October 7, 2026, down 0.62 percent from NZD 6.49. H1 revenue reached NZD 762 million after 105 percent growth.

SCL, NZSCLE0002S8, Illustration mit AI erstellt.

Scales Corporation (ISIN NZSCLE0002S8) was trading at NZD 6.45 on the NZX on October 7, 2026 at 3:58 p.m. NZDT, down 0.62 percent from NZD 6.49. The latest operating picture combines first-half revenue growth of 105 percent with a wider range of execution risks across the group, according to Yahoo Finance in its August 26, 2026 transcript.

Revenue reached NZD 762 million

For the six months ended June 30, 2026, revenue reached NZD 762 million, while underlying EBITDA rose 18 percent to NZD 102 million. Underlying net profit after tax attributable to shareholders increased 7 percent to NZD 52 million, and underlying earnings per share rose NZD 0.02 to NZD 0.36.

The scale of the revenue increase reflects the consolidation of the Edible Proteins business from the third quarter of fiscal 2025. Operating expenses as a share of revenue declined from 8 percent in the first half of 2025 to 5.5 percent in the first half of 2026, giving investors a clearer measure of operating leverage than revenue growth alone.

Guidance rises but Esro weighs

Yahoo Finance reported that Scales raised fiscal 2026 underlying net profit after tax guidance to NZD 55 million to NZD 60 million. Management also highlighted Middle East disruption, final apple pricing and tight protein supply as factors that could affect the second half.

Esro Petfood remains the sharper counter-factor. Scales recognized a NZD 19.7 million impairment provision related to a loan to the joint venture in the first half, excluding it from underlying results, while the business recorded a NZD 3 million loss for Scales' 50 percent share. The company later acquired the remaining 50 percent for nominal consideration, as NZX reported on September 14, 2026.

Stock sits below its yearly high

At NZD 6.45, Scales Corporation stock was 14 percent below its 52-week high of NZD 7.50 and NZD 0.86 above its 52-week low of NZD 5.59 on October 7, 2026. Its market capitalization stood at NZD 935.4 million, with 123,111 shares traded at the cited time.

Consensus data from Investing.com show a Buy rating from two analysts, including one Buy and one Hold. The average 12-month price target is NZD 7.68, with a high of NZD 8.00 and a low of NZD 7.35, placing the average target 19.1 percent above the NZD 6.45 market price.

Scales stock trades at NZD 6.45

Scales Corporation stock was last at NZD 6.45 on the NZX on October 7, 2026 at 3:58 p.m. NZDT, down 0.62 percent from the prior close. The combination of upgraded guidance and the Esro turnaround will determine whether the strong first-half comparison converts into a stronger second half.